I would. Thank you for the opportunity.
I think the short answer is billions of dollars in marketing. That is how the fact that opioids and other medications are addictive was overlooked through all of this. They are overlooked by physicians and overlooked by regulators, because the people marketing the medications know what they're doing when they approach regulators and they know what they're doing when they approach physicians, and they have billions of dollars behind them to change people's minds.
If you want another illustration of how it happens, I think you can refer back to some of the comments made in this committee today by the president of Purdue, who's made similar comments about the new formulation of oxycodone that they are marketing today.